Skip to main content
. 2023 Oct 17;63(2):1178–1213. doi: 10.1007/s10943-023-01932-2

Table 7.

Trust toward biobanking institutions

Definitely not Rather not I do not know Rather yes Definitely yes Median (IQR) p Rank-biserial correlation 95% CI for Rank-biserial correlation
Lower Upper
Would you donate the sample of your biological material to research to
Medical university
 Religious students (RS) 9 21 17 197 212 4 (4–5) < 0.001 0.165 0.103 0.226
 Nonreligious students (NRS) 4 28 20 348 644 5 (4–5)
Public clinical hospital
 RS 16 68 28 216 128 4 (4–5) < 0.001 0.099 0.036 0.161
 NRS 19 126 53 475 371 4 (4–5)
Private clinical hospital
 RS 23 83 29 220 101 4 (3–4) < 0.01 0.078 0.015 0.141
 NRS 35 160 62 503 284 4 (4–5)
Polish biobank
 RS 17 39 35 265 100 4 (4–4) < 0.05 0.073 0.009 0.136
 NRS 25 93 69 555 302 4 (4–5)
Foreign biobank
 RS 47 118 40 185 66 4 (2–4) < 0.001 0.198 0.137 0.259
 NRS 33 176 112 484 239 4 (3–4)
Private biobank
 RS 50 116 53 183 54 4 (2–4) < 0.001 0.105 0.041 0.167
 NRS 67 234 133 433 177 4 (2–4)
Public biobank
 RS 31 86 54 223 62 4 (2–4) < 0.001 0.136 0.073 0.198
 NRS 29 134 125 556 200 4 (3–4)
Polish pharmaceutical company
 RS 61 122 47 177 49 3 (2–4) < 0.01 0.094 0.030 0.156
 NRS 95 226 140 448 135 4 (2–4)
Foreign pharmaceutical company
 RS 87 143 49 133 44 2 (2–4) < 0.001 0.157 0.095 0.219
 NRS 113 264 146 390 131 3 (2–4)
Would you donate to a biobank if your biological samples would be accessible to:
Only researchers from the institution one donated to
 RS 4 6 10 162 274 5 (4–5) < 0.001 0.137 0.074 0.199
 NRS 4 5 10 259 766 5 (4–5)
Researchers from domestic scientific institutions
 RS 11 34 20 242 149 4 (4–5) < 0.001 0.128 0.065 0.190
 NRS 7 73 25 477 462 4 (4–5)
Researchers from domestic commercial companies, including pharmaceutical industry
 RS 72 161 37 139 47 2 (2–4) < 0.01 0.082 0.018 0.145
 NRS 138 311 102 363 130 3 (2–4)
Researchers from foreign scientific institutions
 RS 38 57 28 233 100 4 (3–4) < 0.001 0.236 0.175 0.295
 NRS 28 70 45 491 410 4 (4–5)
Researchers from foreign commercial companies, including pharmaceutical industry
 RS 100 166 38 117 35 2 (2–4) < 0.001 0.146 0.083 0.207
 NRS 159 322 103 332 128 3 (2–4)
Polish and foreign insurance companies
 RS 207 176 31 30 12 2 (1–2) ns 0.028 − 0.036 0.091
 NRS 467 370 83 81 43 2 (1–2)
Government institutions
 RS 208 149 42 48 9 2 (1–2) < 0.01 − 0.079 − 0.142 − 0.016
 NRS 556 301 78 82 27 1 (1–2)
Police
 RS 178 133 53 78 14 2 (1–3) < 0.01 − 0.086 − 0.149 − 0.023
 NRS 481 301 86 151 25 2 (1–3)
When should a research biobank ask the donor for permission to use one’s samples?
Before every new research
 RS 13 59 8 113 263 5 (4–5) < 0.001 − 0.169 − 0.230 − 0.106
 NRS 51 218 53 266 456 4 (2–5)
If a new research differs from the original
 RS 10 32 5 118 291 5 (4–5) < 0.001 − 0.108 − 0.171 − 0.045
 NRS 31 107 34 308 564 5 (4–5)
If it is going to be used by researchers outside the institution one donated to
 RS 4 16 7 77 352 5 (5–5) < 0.01 − 0.072 − 0.135 − 0.009
 NRS 18 67 16 207 736 5 (4–5)
If it is going to be used by foreign institutions
 RS 3 19 7 87 340 5 (4–5) < 0.001 − 0.124 − 0.186 − 0.061
 NRS 21 103 22 235 663 5 (4–5)
Does not have to ask if the doner consent while donating
 RS 205 99 25 70 57 2 (1–4) < 0.01 0.098 0.035 0.161
 NRS 362 253 110 178 141 2 (1–4)

The statistically significant results are given in boldface

ns statistically not significant